| Financial Year |
March 31 2023 |
| Monetary Funds |
1,902,898,116.78 |
| Held-for-trading Financial Assets |
155,003,224.30 |
| Notes Receivable |
-- |
| Accounts Receivable |
80,110,000.69 |
| Advances to Suppliers |
9,367,183.84 |
| Other Receivables |
10,667,009.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
102,445,723.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,822,134.94 |
| Total Current Assets |
2,266,313,393.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
11,826,152.14 |
| Investment Properties |
-- |
| Fixed Assetes |
70,807,945.85 |
| Under-construction Projects |
12,042,155.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
12,235,335.52 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
61,923,078.03 |
| Deferred Income Tax Assets |
42,805,584.36 |
| Other Non-Current Assets |
206,280,278.86 |
| Sub-Total of Non-Current Assets |
499,870,913.70 |
| Total Assets |
2,766,184,307.54 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
34,911,181.60 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,691,304.31 |
| Taxes Payable |
7,289,333.53 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,658,036.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
21,083,573.74 |
| Other Current Liabilities |
132,696.90 |
| Sub-Total of Current Liabilities |
90,211,078.38 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,093,428.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
59,680,480.83 |
| Total Liabilities |
149,891,559.21 |
| Paid-In Capital(Or Share Stock) |
80,000,000.00 |
| Capital Surplus |
2,142,590,554.03 |
| Surplus Reserve |
40,000,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
349,578,151.36 |
| Minority Stockholder's Interest |
3,370,477.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,612,922,271.33 |
| Owner's Equity（Stockholder's Equity） |
2,616,292,748.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,766,184,307.54 |
